Vistin Pharma ASA: Second quarter and first half 2022 financial results
Oslo, Norway, 19th of August 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Oslo, Norway, 19th of August 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment…
SINGAPORE, Aug 19, 2022 – (ACN Newswire) – Taiwan Excellence will be participating for the…
The company’s disciplined and deliberate financial strategy, strong cash position aligned with the November 2022…
Internet City, Dubai–(Newsfile Corp. – August 19, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – August 18, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – August 18, 2022) – LBank Exchange, a global digital asset…
– In Adults with Pyruvate Kinase (PK) Deficiency Who Are Regularly Transfused, PYRUKYND® Demonstrated a…
Calgary, Alberta–(Newsfile Corp. – August 18, 2022) – Cleantek Industries Inc. (TSXV: CTEK) (“Cleantek” or…
MUMBAI, INDIA, Aug 19, 2022 – (ACN Newswire) – MuskMelon NFT, a utility token developed…
Enterprise sales productivity platform ranked in top half of 2022 Inc. 5000 list; New customers…
FDA granted Priority Review designation PDUFA target action date is February 17, 2023 FDA stated…
In advance of the abstract publication, POINT hosted an educational webinar entitled “Understanding the PNT2002…
WINNIPEG, Manitoba, Aug. 18, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Second quarter 2022 net revenue increased 46% year-over-year to $4.1 million Second quarter 2022 total…
AMITYVILLE, N,Y., Aug. 18, 2022 (GLOBE NEWSWIRE) — The Greenrose Holding Company Inc. (OTC: GNRS,…
LEXINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Relay Therapeutics to host a conference call on September 12th at 8:00 am E.T. CAMBRIDGE,…
NEW HAVEN, Conn., Aug. 18, 2022 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage…
ARLINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA) (“Kala” or the…